Loading...
Ramsay Health Care Limited
RMYHY•PNK
Healthcare
Medical - Care Facilities
$6.23
$0.00(0.00%)
Ramsay Health Care Limited (RMYHY) Financial Performance & Income Statement Overview
Review Ramsay Health Care Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
12.13%
↑ 12.13%
Operating Income Growth
41.89%
↑ 41.89%
Net Income Growth
198.12%
↑ 198.12%
Operating Cash Flow Growth
1.75%
↑ 1.75%
Operating Margin
8.92%
↑ 8.92%
Gross Margin
10.90%
↑ 10.90%
Net Profit Margin
5.33%
↑ 5.33%
ROE
18.26%
↑ 18.26%
ROIC
8.90%
↑ 8.90%
Ramsay Health Care Limited (RMYHY) Income Statement & Financial Overview
Review Ramsay Health Care Limited's (RMYHY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $8.58B | $8.09B | $7.87B | $7.11B |
| Cost of Revenue | $7.74B | $7.32B | $7.16B | $6.55B |
| Gross Profit | $838.90M | $771.80M | $709.60M | $550.40M |
| Gross Profit Ratio | $0.10 | $0.10 | $0.09 | $0.08 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $344.20M | $329.60M | $322.50M | $288.20M |
| Operating Expenses | $344.20M | $329.60M | $322.50M | $288.20M |
| Total Costs & Expenses | $8.08B | $7.65B | $7.48B | $6.84B |
| Interest Income | $2.90M | $4.10M | $16.60M | $23.30M |
| Interest Expense | $306.40M | $313.60M | $279.80M | $234.40M |
| Depreciation & Amortization | $550.90M | $531.20M | $523.90M | $476.90M |
| EBITDA | $1.05B | $1.05B | $911.00M | $739.10M |
| EBITDA Ratio | $0.12 | $0.12 | $0.12 | $0.10 |
| Operating Income | $494.70M | $442.20M | $387.10M | $262.20M |
| Operating Income Ratio | $0.06 | $0.05 | $0.05 | $0.04 |
| Other Income/Expenses (Net) | -$312.90M | -$239.40M | -$186.50M | $64.30M |
| Income Before Tax | $181.80M | $202.80M | $200.50M | $326.70M |
| Income Before Tax Ratio | $0.02 | $0.03 | $0.03 | $0.05 |
| Income Tax Expense | $54.00M | $67.30M | $79.50M | $102.00M |
| Net Income | $130.20M | $758.50M | $103.70M | $194.40M |
| Net Income Ratio | $0.02 | $0.09 | $0.01 | $0.03 |
| EPS | $0.53 | $3.29 | $0.42 | $0.83 |
| Diluted EPS | $0.53 | $3.28 | $0.42 | $0.83 |
| Weighted Avg Shares Outstanding | $228.80M | $228.30M | $228.10M | $227.80M |
| Weighted Avg Shares Outstanding (Diluted) | $229.52M | $228.80M | $228.79M | $228.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan